chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The patient received a dose of the vaccine following temperature excursions on unknown dates; No adverse event; This spontaneous report as received from a medical assistant refers to a current 5-month-old patient of unknown gender.  The patient's concurrent conditions, medical history and concomitant medications were not provided.   On an unknown date, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ)  (lot # S013439 with expiration date 03-MAR-2021, lot # S013436 with expiration date 30-JAN-2021, and lot # S006050 with expiration date 12-DEC-2020) underwent a temperature excursion.   Temperature Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) Time frame 7 hours 30 minutes Previous temperature excursion? yes, Total Time and LOWEST Temperature BELOW 36°F/2°C (0C) for 8 hours 30 minutes Was call because of a "data logger"? yes  On an unknown date, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) at a dose of 2 ml (route not provided) as prophylaxis. No adverse events were reported.  This is one of several reports received from the same reporter  This spontaneous report as received from a other health professional refers to a patient of unknown age.    On an unknown date the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot # S006050, 2 milliliter for prophylaxis.       On an unknown date the patient experienced product storage error and no adverse event.    The outcome of product storage error and no adverse event is unknown.   The reporter considered product storage error and no adverse event to be not assessed to Rotavirus Vaccine, Live, Oral, Pentavalent(ROTATEQ).     {Additional information has been requested. / Additional information is not expected.}; Sender's Comments:  US-009507513-2005USA003382: US-009507513-2005USA004545: US-009507513-2005USA004950: US-009507513-2005USA004951: US-009507513-2005USA004952: US-009507513-2005USA004953: US-009507513-2005USA004954: US-009507513-2005USA004955: US-009507513-2005USA004956: US-009507513-2005USA004957: US-009507513-2005USA004958: US-009507513-2005USA004959: US-009507513-2005USA004960: US-009507513-2005USA004961: US-009507513-2005USA004962: US-009507513-2005USA004963: US-009507513-2005USA004964: US-009507513-2005USA004965: US-009507513-2005USA004966: US-009507513-2005USA004967: US-009507513-2005USA004968: US-009507513-2005USA004969: US-009507513-2005USA004970: US-009507513-2005USA004971: US-009507513-2005USA004972: US-009507513-2005USA004973: US-009507513-2005USA004974: US-009507513-2005USA004975: US-009507513-2005USA004976: US-009507513-2005USA004977: US-009507513-2005USA004978: US-009507513-2005USA004980: US-009507513-2005USA004981: US-009507513-2005USA004982: US-009507513-2005USA004983: US-009507513-2005USA004984: US-009507513-2005USA004985: US-009507513-2005USA004986: US-009507513-2005USA004987: US-009507513-2005USA004988: US-009507513-2005USA004989: US-009507513-2005USA004990: US-009507513-2005USA004991: US-009507513-2005USA004992: US-009507513-2005USA004993:
3 weeks after 2nd shot the Humira completely quit working.  PsA pain got severe. After experiencing COVID symptoms in October had a major psoriasis breakout while still taking Humira/methotrexate.
Burning pain in arms and legs, swelling in right knee. Onset within days of immunization. Had similar burning pain with previous covid vaccination that lasted 6 months.
Erythema & induration at site of injection fever & chills (t max 103 degrees F). Vacc given at 0900 on 27 Jan, sympts at 1800.
Left was sore on 1/18. 1/19 Woke up very congested.  1/19 went into work, she lost her voice and eyes, face and neck swollen- felt like her throat was swelling
Six days following the 2nd Moderna shot, I had a violent and unexpected Vertigo episode.  I went back to bed and a couple hours later I didn't have Vertigo anymore.  Since that time I have been feeling lightheaded every day and have suffered Vertigo episodes every couple of weeks.  On August 10 the Vertigo came back most recently.  The lightheadedness became more severe.  I went to urgent care on August 11.  I went to ENT Vertigo specialist on August 16.  I have been doing Epley exercises twice per day since ENT visit.  Feel moderately better than before, but I still don't feel well.  I have arranged for vestibular physical therapy starting in about 8 days and hope that will bring me back to normal.
Cellulitis developed at PREVNAR 13 injection site (upper left arm). Immunization administered at 11:40 AM, July 8th, 2015. Pt developed symptoms within two days and contacted pharmacy around 10 AM on 7/13/15.
Got 1st dose, forgot 2nd; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: Got 1st dose, forgot 2nd). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt date: 18-MAR-2023 This case was reported by a patient (daughter/ son) via interactive digital media. The reporter reported that, her/his mom got her first vaccine and when she had to go for the second one she didn't come back, she forgot it. Now she has to get two again or just get the vaccine that is missing. The follow-up could not be possible as no contact details were available. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.
-Very sore arm at injection site -Sick all day  -Bad headache  -Rash on my Right Hip
Site: Itching at Injection Site-Medium, Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Itch Generalized-Mild
3 hours after receiving VARIVAX, MENACTRA and BOOSTRIX, developed fever up to 104 and myalgias, seemed better by 9-18-08.  Also sl. swelling of shot sight.
?COVID arm? developed 1 week after first dose: itching, redness, warmth, and tingling at site of injection.
Began flu-like symptoms on evening of injection, then developed local reaction with a bruise at injection site, with redness at site down to elbow with mild edema and warm and sore to touch. Applied local moist heat and cool compress and took Aleve prn.
6hr p/vax pt began having swelling of lips, face, neck & tongue, coughing;seen in office & given Medrol dose pace & DPH;Denies any allergy to eggs;
Swelling, redness and itching  in arm pit of left arm and into lymph nodes. itching only when rubbed.
Received vaccine 11/03/2005, admitted in heart failure, myocarditis 11/10/2005, Died 11/10/2005. Increasingly cranky for 2 days procedding admission to hospital.
suffered from pain in the vaccine area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent reported for her son (Patient) that: A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "suffered from pain in the vaccine area".  Additional Information: The reporter reported that her son got the COVID vaccine and he suffered from pain in the vaccine area. He lives in the same house as she and he got pain in the arm, just a little in the area.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
A nurse reported the occurrence of an injection site reaction in a 4 year old male who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed for prophylaxis. The subject had no known allergies and no adverse experiences following receipt of previous immunizations. Other medical history included epistaxis (03FEB2003). Concurrent conditions were not reported. There were no concurrent medications. the subject received his fifth injection of Infanrix on 01APR2003 into his left arm, a one inch needle with proper technique was used for the injection. He also received injections of inactivated poliomyelitis virus vaccine and measles, mumps and rubella virus vaccine in a separate limp. On 03APR2003, the subject presented to the vaccine provider with an injection site reaction characterized by swelling, itching and redness involving the upper left arm. The subject had full range of motion. The vaccine provider made a diagnosis of DTaP reaction and prescribed cool compresses, ibuprofen,  and diphenhydramine. The outcome of the events was unknown as of 20MAY2003.
This report described the occurrence of Lyme arthritis and/or Lyme disease in a 59 year old female pt who received Lyme disease vaccine recombinant OspA (LYMErix) for prophylaxis. This report was received as part of litigation proceedings, and has not been verified by a physician or other health care professional. The pt received injections of LYMErix on 4/9/99, 5/14/99, "and 12 months later" "according to the client." On 1/12/04, the pt's attorney alleged that the pt developed "treatment resistant Lyme arthritis and/or treatment resistant Lyme disease," with symptoms including "numbness in her toes, finger, and lump on her right elbow, severe shoulder pain, elbow pain, hand pain, hearing loss, rashes, droopy face, right hip pain and stiffness." The attorney further alleged that the pt suffered pain that was described as "at times debilitating" and which "severely limited her employment options and opportunities." According to the attorney, the pt was under the care of a neurologist, and received anti-inflammatory and other medications without relief of symptoms. Information from Annual Follow-up report states this adverse event was received through litigation process. Additional information regarding the event, including outcome information, is being pursued throught the litigation process and will be reported if obtained.
after the 1st dose I just felt a headache; joint pain; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 69-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in arm left on 22Feb2021 at 10:00 (Batch/Lot Number: EN6200) (age at vaccination 69-year-old) as dose 1, single for covid-19 immunisation at Pharmacy or Drug Store. Medical history included high cholesterol and atrial fibrillation from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received any other medications within 2 weeks of vaccination included lovastatin, metoprolol and aspirin (acetylsalicylic acid). Prior to vaccination, was the patient diagnosed with COVID-19 was Unknown. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced on an unspecified date, after the 1st dose i just felt a headache and joint pain. The adverse event result in Doctor or other healthcare professional office/clinic visit. The outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Day 1: Flu like symptoms/weakness, day 2-3-4 flu like symptoms got worse. Day 5 - Numbness in right side of face, including sense of swelling (not visible). Day 8 - Blurriness in left eye, loss of vision - after 3 weeks symptoms remain the same.
Day 2 : fever chills and flu like symptoms Day 5 : full cardiac arrest: with no previous heart issue
After client received hep B #1 dose of 4/9/02, he proceeded to go tanning and used a tanning accelerant. After tanning, next day client had a itchy palm and foot on L side. Had hives around beltline R and L side and instead of thighs. Eventually went away. After 2nd hep B 5/10/02 he had no rxn.
Started getting short of breath and coughing up mucus; Went to the ER; Was given an X-ray and given a COVID-19 test and it was positive; Was given a breathing treatment and was sent back home; Was told to home back if things got worse; Started feeling shortness of breath and coughing mucus again, went back to the ER; Prescribed remdesivir and started feeling better; Am left with constant lung pressure of not being able to get enough air the way I used to.
achiness; soreness at site of vaccination; shivering/ chills; headache; fever; vomiting; Diarrhea; This case was reported by a consumer via other manufacturer and described the occurrence of pain in a 57-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pain (1st dose received in July 2020, refer case US2020AMR254715). Concurrent medical conditions included egg allergy.   In October 2020, the patient received the 2nd dose of Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. On an unknown date, less than 3 months after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced pain, injection site pain, shivering, headache, fever, vomiting and diarrhea. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the pain, injection site pain, shivering, headache, fever, vomiting and diarrhea were unknown.   It was unknown if the reporter considered the pain, injection site pain, shivering, headache, fever, vomiting and diarrhea to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The age at vaccination was not reported, however could be 56 or 57 years. The patient received Shingrix vaccine and Flu vaccine on same day. The patient reported experienced every adverse reaction possible. The symptoms listed were achiness, soreness at site of vaccination, chills, shivering, headache, fever, vomiting, and diarrhea. The reporter consent to call her back.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR254715:same reporter, 1st dose
Initially, felt pain at the injection sites. Began noticing pain radiating into right armpit at 11:30 PM, took Motrin for pain relief. Awoke in the moring of 10/25/2010, noted warmth at the injection site, redness extending from the injection down into the the armpit and two hard lumps in the armpit region. Patient reported headache without fever. Saw MD, received antibiotic prophylaxis for diagnosis of cellulitis.
itchy red rash; itchy red rash; Injection site red; Injection site swollen; injection site tender to touch; This case was reported by a consumer and described the occurrence of injection site erythema in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10th July 2019, the patient received the 1st dose of Shingrix. On 13th July 2019, 3 days after receiving Shingrix, the patient experienced itchy rash and red rash. In July 2019, the patient experienced injection site erythema, injection site swelling and injection site tenderness. On an unknown date, the outcome of the injection site erythema, injection site swelling, injection site tenderness, itchy rash and red rash were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling, injection site tenderness, itchy rash and red rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received a dose of Shingrix in the unknown arm. The patient's injection site became red, swollen and very tender to the touch. On 13th July 2019 in the morning, the patient woke with a localized rash in antecubital area of arm where the patient was vaccinated. It was itchy and red. No other symptoms were reported. The patient inquired, do he need to be concerned and still need to take second injection.
CHIEF COMPLAINT SOB   HISTORY OF PRESENT ILLNESS Patient is a 61 y.o. female, vaccinated with past medical history notable for Crohn's disease, Short Bowel syndrome on TPN, Amyloidosis without evidence of cardiac involvement c/B ESRD on Dialysis MWF, Chronic Anemia who presents with COVID Pneumonia.     The patient reports that her symptoms first developed on 9/21. She reports cough, fevers, chills, congestion, and diarrhea out of her rectum (not out of her ostomy) with diminished ability to tolerate her TPN and vomiting with oral intake.  Additionally, her son was swab for COVID on 9/25 which came back positive today. With regards to her diarrhea, she reports increased frequency of non-bloody, watery stoo CHIEF COMPLAINT SOB   HISTORY OF PRESENT ILLNESS Patient is a 61 y.o. female, vaccinated with past medical history notable for Crohn's disease, Short Bowel syndrome on TPN, Amyloidosis without evidence of cardiac involvement c/B ESRD on Dialysis MWF, Chronic Anemia who presents with COVID Pneumonia.     The patient reports that her symptoms first developed on 9/21. She reports cough, fevers, chills, congestion, and diarrhea out of her rectum (not out of her ostomy) with diminished ability to tolerate her TPN and vomiting with oral intake.  Additionally, her son was swab for COVID on 9/25 which came back positive today. With regards to her diarrhea, she reports increased frequency of non-bloody, watery stools passing rectally which does not occur very frequently. She does not make urine. She reports that she has had progressive shortness of breath over the last few days, and when she checked her pulse ox at home today it was in the 80s. In this setting she called EMS and  was placed on oxygen and transported to the emergency department. She denies headache, changes in vision, lower extremity edema, or abdominal pain.   On arrival to the ED she was tachycardic in the 100s and intermittently tachypneic up to 41. She arrived on 4L nasal canula and was normotensive. Her workup is notable for Hbg 9.9 (baseline 10.0), Plt 102, WBC 7.2, Na 136, K 3.9, BUN 30, Cr. 5.38, Mg 1.6, D. Bili 0.5, ALT 53, AST 61, and Alk Phos 248. She tested positive for COVID. Her CXR was notable for new peripheral patchy airspace opacities consistent with known COVID-19 infection. Otherwise unchan. Interventions in the ED included 1L NS.    On arrival to the pulmonary service, the patient reports she feels much more comfortable being here than at home. Notably, she is febrile to 39.1. She is adamant that she does not want Remdesivir treatment as she has read that the WHO does not recommend it and has also read things about terrible outcomes. She is requesting treatment with convalescent plasma, which I explained is no longer standard of care. She otherwise reports no additional concerns or complaints recently.
20 minutes after recieved Fluzone HD and Zostavax patient complained of feeling light headed and weak. Patient refused 911 service. She sat at the store for 20 minutes while a pharmacist monitor her symptoms and then she left with her husband.
Pt vaccinated with Zostavax 4-5-07, waited x 30 min post vaccine; noted 3 mm wheal at injection site no respiratory sx or rash, given Zyrtec 10 mg now 4-9-07. Pt contacted provider, reported that she developed large red tender warm area surrounding injection site measuring 3"x6" took benadryl, erythema area now size of quarters
Hives showing up on neck 2 weeks after injection. 2nd day- hives spreading and moving across the body, itchy, Benadryl helped. 3rd day- hives became bumpy and itchy.
first dose of Shingrix "in september" / dose two (late second dose); This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in September 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows:  The age at vaccination was not applicable for this report. The age group was not reported but was captured as adult as per vaccine indication. Till the time of reporting patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The health care provider contacted medical information for instructions on how to proceed with dose two (late second dose). No more information was available. The reporter did not consent to follow up.
On January 7, I was outside with my kids and felt very fatigued and nauseated. Three or four days later while on phone with friend I had an electrical shock come through my body, (arms, chest and upper body). That happened about three or four times over the next ten minutes. Over the next few days I began to be sensitive to sounds and was unable to sleep. There was a buzzing, like an electrical current, in my body. Waking up with night sweats. I would feel "dropping" sensations while laying down. Very sensitive to light. I developed heaviness in my forehead. I began to get vision lags each time I turned my head. I developed a rosacea-like rash on my face. Several times my tongue has gone numb. Disorientation and nausea common. Heavy eyes, strained eyes, rash on bikini line, fullness and ringing in my ear. I visited the ENT. Balance issues, but not vertigo. Vestibular migraines. Was told to change my diet and get anxiety under control before he would treat me. Tingling in my toes, but maybe after first dose. Went to Neurologist. Tested for MS and touch reactions. Visited the eye doctor but vision was 20/20. However, my vision to me was off, like depth proception was off. He told me maybe I had dry eye and gave me eye drops. Visited the primary care doctor. He wanted to treat me for anxiety. I visited a Neuro Ophthalmologist. He was the first one that told me that it may be a side effect from the vaccine. Suggested vestibular rehab and some FL41 lenses for my eyes. Visited Acupuncturist and she was able to get my Vagus Nerve to calm down. I visited Rheumatologist but nothing remarkable. During vestibular rehab she noticed I had an eye convergence issue and was told I needed to see Neuro Optometrist. They confirmed the eye convergence insufficiency. I am now going to vision therapy. I have special glasses with prism lenses. Another symptom over the last few weeks I felt like I was getting worse I get internal tremors when I get over exerted but really my normal activities. I will lay down but I get the electric current through my body. again. During the last several months I have also had at least two ear infections and I was given antibiotics and steroid. It was interesting because after I took the steroid I was able to go into stores without nausea from sounds and light. One month after that I had another double ear infection and a terrible cold. I had to go to an urgent care for help. D-Dimer was found to be elevated but no blood clots were found.
This spontaneous report as received from a pharmacist refers to multiple unspecified patients of unknown age and gender. Pharmacist reported that on an unknown dates, multiple unspecified patients may have been administered PNEUMOVAX23 (dose, lot number and route were not reported), that went through an unsupported temperature excursion. Concomitant medications were not reported. No adverse effects reported. This case is linked to cases 1308USA011687 and 1308USA010000 via same reporter link. Additional information has been requested.